Canada’s IP system is undergoing a number of changes, from the impact of a new trade deal to the effects of a Supreme Court ruling, as WIPR finds out.
There is significant change on the horizon for Canada’s IP system. One development that will have a big impact on the patenting framework is the Comprehensive Economic and Trade Agreement (CETA), a free trade deal between Canada and the EU which aims to cut tariffs on exports between the two regions.
According to John Norman, partner at Gowling WLG, CETA aims to lower tariffs by 98% so that only 2% of goods exported between Canada and the EU will have tariffs associated with them.
“The hope is that both regions will have to level the playing field so that goods on both sides of the equation get equal protection.”
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Trade, trademarks, Canada, Canadian IP system, Supreme Court, , pharmaceutical. CETA, generic company
